Table 1.

Types of biomarkers for AIT

Identification and validation of biomarkers assessing the probability of response to treatment of AIT before it is initiated

Identification and validation of biomarkers assessing the safety of AIT before it is initiated

Identification and validation of biomarkers confirming the efficacy of AIT in patients receiving AIT (short and long term)

Identification and validation of biomarkers predicting the long-term effects of AIT before it is stopped

Identification and validation of biomarkers predicting the relapse of symptoms when AIT is stopped